Immuno-intervention for the Induction of Transplantation Tolerance Through Mixed Chimerism

Overview

Journal Semin Immunol

Specialty Allergy & Immunology

Date 2011 Aug 16

PMID 21839648

Citations 30

Authors

David H Sachs

Megan Sykes

Tatsuo Kawai

A Benedict Cosimi

Affiliations

Soon will be listed here.

Abstract

The induction of transplantation tolerance could liberate organ transplant recipients from the complications of life-long chronic immunosuppression. The original description of tolerance induction through mixed hematopoietic chimerism in mice utilized lethal whole body irradiation as the preparative regimen for achieving mixed chimerism. While such a regimen might be acceptable for treatment of patients with malignancies, which might also respond to the therapeutic effects of radiation, its toxicity would be unacceptable for patients in need only of an organ transplant. Graft-vs.-host disease, which is frequently a complication of mismatched bone marrow transplantation, would likewise be unacceptable for ordinary clinical transplantation. Therefore, as we have extended the use of this modality for tolerance induction from mice to large animal models, we have attempted to design preparative regimens that avoid both of these complications. In this article, we review our studies of mixed chimerism in mice, miniature swine and monkeys, as well as the results of our recent clinical studies that have extended this treatment modality to a series of kidney transplant patients who have been successfully weaned from all immunosuppression while maintaining stable renal function for up to 8 years.

Citing Articles

Chimeric Cell Therapies as a Novel Approach for Duchenne Muscular Dystrophy (DMD) and Muscle Regeneration.

Budzynska K, Siemionow M, Stawarz K, Chambily L, Siemionow K Biomolecules. 2024; 14(5).

PMID: 38785982 PMC: 11117592. DOI: 10.3390/biom14050575.

Transplant Tolerance, Not Only Clonal Deletion.

Hall B, Verma N, Tran G, Hodgkinson S Front Immunol. 2022; 13:810798.

PMID: 35529847 PMC: 9069565. DOI: 10.3389/fimmu.2022.810798.

The Mandible Ameliorates Facial Allograft Rejection and Is Associated with the Development of Regulatory T Cells and Mixed Chimerism.

De Paz D, Avina A, Cardona E, Lee C, Lin C, Lin C Int J Mol Sci. 2021; 22(20).

PMID: 34681764 PMC: 8537927. DOI: 10.3390/ijms222011104.

Evolution of haematopoietic cell transplantation for canine blood disorders and a platform for solid organ transplantation.

Graves S, Storb R Vet Med Sci. 2021; 7(6):2156-2171.

PMID: 34390541 PMC: 8604109. DOI: 10.1002/vms3.601.

Innate Immune Determinants of Graft-Versus-Host Disease and Bidirectional Immune Tolerance in Allogeneic Transplantation.

Hamers A, Joshi S, Pillai A OBM Transplant. 2021; 3(1).

PMID: 33511333 PMC: 7839993. DOI: 10.21926/obm.transplant.1901044.

References

Colby C, Chang Q, Fuchimoto Y, Ferrara V, Murphy M, Sackstein R . Cytokine-mobilized peripheral blood progenitor cells for allogeneic reconstitution of miniature swine. Transplantation. 2000; 69(1):135-40. DOI: 10.1097/00007890-200001150-00023. View

Boyd R, Hugo P . Towards an integrated view of thymopoiesis. Immunol Today. 1991; 12(2):71-9. DOI: 10.1016/0167-5699(91)90161-L. View

Newell K, Larsen C . Toward transplantation tolerance: a large step on a long road. Am J Transplant. 2006; 6(9):1989-90. DOI: 10.1111/j.1600-6143.2006.01481.x. View

Khan A, Tomita Y, Sykes M . Thymic dependence of loss of tolerance in mixed allogeneic bone marrow chimeras after depletion of donor antigen. Peripheral mechanisms do not contribute to maintenance of tolerance. Transplantation. 1996; 62(3):380-7. DOI: 10.1097/00007890-199608150-00014. View

Mapara M, Kim Y, Wang S, Bronson R, Sachs D, Sykes M . Donor lymphocyte infusions mediate superior graft-versus-leukemia effects in mixed compared to fully allogeneic chimeras: a critical role for host antigen-presenting cells. Blood. 2002; 100(5):1903-9. DOI: 10.1182/blood-2002-01-0023. View

Ildstad S, Sachs D . Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts. Nature. 1984; 307(5947):168-70. DOI: 10.1038/307168a0. View

Baron C, McMorrow I, Sachs D, LeGuern C . Persistence of dominant T cell clones in accepted solid organ transplants. J Immunol. 2001; 167(8):4154-60. DOI: 10.4049/jimmunol.167.8.4154. View

Wu A, Yamada K, Ierino F, Vagefi P, Sachs D . Regulatory mechanism of peripheral tolerance: in vitro evidence for dominant suppression of host responses during the maintenance phase of tolerance to renal allografts in miniature swine. Transpl Immunol. 2003; 11(3-4):367-74. DOI: 10.1016/S0966-3274(03)00006-6. View

Sayegh M, Fine N, Smith J, Rennke H, Milford E, Tilney N . Immunologic tolerance to renal allografts after bone marrow transplants from the same donors. Ann Intern Med. 1991; 114(11):954-5. DOI: 10.7326/0003-4819-114-11-954. View

10.

Fuchimoto Y, Huang C, Yamada K, Shimizu A, Kitamura H, Colvin R . Mixed chimerism and tolerance without whole body irradiation in a large animal model. J Clin Invest. 2000; 105(12):1779-89. PMC: 378506. DOI: 10.1172/JCI8721. View

11.

Gleit Z, Fuchimoto Y, Yamada K, Melendy E, Monajati L, Coburn R . Variable relationship between chimerism and tolerance after hematopoietic cell transplantation without myelosuppressive conditioning. Transplantation. 2002; 74(11):1535-44. DOI: 10.1097/00007890-200212150-00010. View

12.

Adams A, Williams M, Jones T, Shirasugi N, Durham M, Kaech S . Heterologous immunity provides a potent barrier to transplantation tolerance. J Clin Invest. 2003; 111(12):1887-95. PMC: 161424. DOI: 10.1172/JCI17477. View

13.

Fudaba Y, Spitzer T, Shaffer J, Kawai T, Fehr T, Delmonico F . Myeloma responses and tolerance following combined kidney and nonmyeloablative marrow transplantation: in vivo and in vitro analyses. Am J Transplant. 2006; 6(9):2121-33. DOI: 10.1111/j.1600-6143.2006.01434.x. View

14.

Sakamoto K, Pennington L, Pescovitz M, McDonough M, MacVittie T, Gress R . Bone marrow transplantation in miniature swine. II. Effect of selective genetic differences on marrow engraftment and recipient survival. Transplantation. 1988; 45(1):27-31. View

15.

Sharabi Y, Sachs D . Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen. J Exp Med. 1989; 169(2):493-502. PMC: 2189213. DOI: 10.1084/jem.169.2.493. View

16.

Kurtz J, Shaffer J, Lie A, Anosova N, Benichou G, Sykes M . Mechanisms of early peripheral CD4 T-cell tolerance induction by anti-CD154 monoclonal antibody and allogeneic bone marrow transplantation: evidence for anergy and deletion but not regulatory cells. Blood. 2004; 103(11):4336-43. DOI: 10.1182/blood-2003-08-2642. View

17.

Graca L, Cobbold S, Waldmann H . Identification of regulatory T cells in tolerated allografts. J Exp Med. 2002; 195(12):1641-6. PMC: 2193557. DOI: 10.1084/jem.20012097. View

18.

Wu Z, Bensinger S, Zhang J, Chen C, Yuan X, Huang X . Homeostatic proliferation is a barrier to transplantation tolerance. Nat Med. 2003; 10(1):87-92. PMC: 2839903. DOI: 10.1038/nm965. View

19.

Sachs D . Tolerance: of mice and men. J Clin Invest. 2003; 111(12):1819-21. PMC: 161433. DOI: 10.1172/JCI18926. View

20.

Tomita Y, Khan A, Sykes M . Role of intrathymic clonal deletion and peripheral anergy in transplantation tolerance induced by bone marrow transplantation in mice conditioned with a nonmyeloablative regimen. J Immunol. 1994; 153(3):1087-98. View